High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$66.9M
$66,862,761
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $71,054 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $284,395 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $605,714 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $704,724 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $874,974 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $505,125 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $256,202 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $70,221 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $70,023 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $23,269 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $62,180 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $251,255 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $127,502 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $473,862 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $119,766 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $143,453 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $121,735 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $297,957 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $285,474 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $104,489 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-30 | $1,354,200Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $12,737 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-30 | $465,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-26 | $1,354,200Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $527,236 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $271,794 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $325,153 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $988,101 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $1,073,491Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $846,689 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $618,046 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $535,680 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-26 | $172,814 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -10.6%
2026-03-23
$1,386,093Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -10.6%
|
2026-03-23 | $1,386,093Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $273,818 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $168,118 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $230,648 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $104,473 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $471,927 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $455,539 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $332,354 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $103,657 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2026-03-23 | $1,354,200Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $85,804 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $235,548 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $270,506 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $342,569 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $153,387 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $311,985 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $306,177 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2026-03-23 | $42,199 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $413,958 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $78,644 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $120,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $119,835 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $196,745 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $99,395 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $257,869 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-12-15 | $513,588 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $178,206 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-15 | $276,968 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -26.5%
2025-12-01
$1,855,492Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -26.5%
|
2025-12-01 | $1,855,492Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-12-01 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $1,363,672Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -16.0%
2025-12-01
$2,011,284Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -16.0%
|
2025-12-01 | $2,011,284Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -34.2%
2025-12-01
$3,624,368Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -34.2%
|
2025-12-01 | $3,624,368Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -13.8%
|
2025-12-01 | $711,143 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $436,188 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-12-01 | $77,549 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $866,330 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $728,414 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -11.8%
2025-11-24
$1,372,575Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -11.8%
|
2025-11-24 | $1,372,575Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $930,076 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $845,233 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $132,592 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $741,168 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $771,745 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -20.4%
2025-11-24
$1,426,403Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -20.4%
|
2025-11-24 | $1,426,403Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -14.0%
|
2025-11-24 | $779,362 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $150,800 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $307,655 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $382,354 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $63,181 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-24 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-24 | $448,658 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -19.1%
2025-11-17
$1,688,978Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -19.1%
|
2025-11-17 | $1,688,978Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -34.8%
2025-11-17
$2,139,487Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -34.8%
|
2025-11-17 | $2,139,487Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -23.9%
2025-11-17
$1,923,425Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -23.9%
|
2025-11-17 | $1,923,425Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $509,602 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $55,726 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-17 | $1,505,861Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $40,024 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $379,761 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $303,397 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $435,783 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -15.9%
|
2025-11-17 | $943,786 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -17.5%
2025-11-17
$1,252,030Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -17.5%
|
2025-11-17 | $1,252,030Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-17 | $205,537 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-17 | $1,560,769Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.2%
2025-11-10
$1,180,598Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.2%
|
2025-11-10 | $1,180,598Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-10 | $3,066,630Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $469,727 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $688,655 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -12.7%
2025-11-10
$1,504,595Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -12.7%
|
2025-11-10 | $1,504,595Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $293,197 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $270,480 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-10 | $481,240 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -10.4%
|
2025-11-10 | $982,479 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.8%
2025-11-10
$2,102,517Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.8%
|
2025-11-10 | $2,102,517Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -23.8%
2025-11-10
$1,519,994Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -23.8%
|
2025-11-10 | $1,519,994Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $655,872 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $464,892 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $42,345 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
Other
|
2025-11-04 | $3,066,630Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.6%
2025-11-04
$2,653,239Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.6%
|
2025-11-04 | $2,653,239Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -39.2%
2025-11-04
$3,195,910Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -39.2%
|
2025-11-04 | $3,195,910Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
EDGEMOND JAMES
• CFO
10b5-1 SellΔOwn -24.2%
2025-11-04
$1,204,662Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 SellΔOwn -24.2%
|
2025-11-04 | $1,204,662Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $157,859 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $52,741 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CFO
10b5-1 Sell
|
2025-11-04 | $730,302 | S | Form 4 |